KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Invested Capital (2019 - 2025)

Castle Biosciences (CSTL) has disclosed Return on Invested Capital for 7 consecutive years, with 0.07% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 9.0% to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07% through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.07% for FY2025, 9.0% down from the prior year.
  • Return on Invested Capital hit 0.07% in Q4 2025 for Castle Biosciences, down from 0.05% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q4 2024 to a low of 0.25% in Q2 2023.
  • Historically, Return on Invested Capital has averaged 0.1% across 5 years, with a median of 0.08% in 2021.
  • Biggest five-year swings in Return on Invested Capital: dropped -13bps in 2023 and later rose 23bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.09% in 2021, then tumbled by -88bps to 0.18% in 2022, then dropped by 0bps to 0.18% in 2023, then soared by 109bps to 0.02% in 2024, then crashed by -557bps to 0.07% in 2025.
  • Business Quant data shows Return on Invested Capital for CSTL at 0.07% in Q4 2025, 0.05% in Q3 2025, and 0.05% in Q2 2025.